Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-244.84M
↓ 99% below average
Average (7y)
$-122.98M
Historical baseline
Range
High:$-6.75M
Low:$-244.84M
CAGR
+67.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-244.84M | -19.4% |
| 2024 | $-205.01M | -37.7% |
| 2023 | $-148.93M | +17.1% |
| 2022 | $-179.72M | -55.1% |
| 2021 | $-115.90M | -84.5% |
| 2020 | $-62.80M | -215.9% |
| 2019 | $-19.88M | -194.5% |
| 2018 | $-6.75M | - |